Skip to main content

Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)

Phase: PHASE2 | Sponsor: Centre Hospitalier St Anne | Compound: Psilocybin

Status
planned
Institution
Centre Hospitalier St Anne
Start date
2025-10-08
End date
2030-06-30
Registry ID
NCT07210112

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.